Day One Biopharmaceuticals, Inc. (DAWN)
- Previous Close
13.21 - Open
13.31 - Bid 14.88 x 200
- Ask 14.91 x 100
- Day's Range
13.23 - 15.10 - 52 Week Range
9.67 - 17.85 - Volume
3,599,821 - Avg. Volume
918,653 - Market Cap (intraday)
1.304B - Beta (5Y Monthly) -1.48
- PE Ratio (TTM)
-- - EPS (TTM)
-2.37 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
36.63
Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genomically defined cancers. Its lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/ refractory low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.
dayonebio.comRecent News: DAWN
Performance Overview: DAWN
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: DAWN
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: DAWN
Valuation Measures
Market Cap
1.15B
Enterprise Value
788.31M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
3.33
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
-3.83
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-35.52%
Return on Equity (ttm)
-55.68%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-188.92M
Diluted EPS (ttm)
-2.37
Balance Sheet and Cash Flow
Total Cash (mrq)
366.35M
Total Debt/Equity (mrq)
0.12%
Levered Free Cash Flow (ttm)
-82.72M
Research Analysis: DAWN
Company Insights: DAWN
Fair Value
Dividend Score
Hiring Score
Insider Sentiment Score
Research Reports: DAWN
Daily – Vickers Top Buyers & Sellers for 09/26/2022
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Daily – Vickers Top Buyers & Sellers for 09/21/2022
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Daily – Vickers Top Buyers & Sellers for 09/16/2022
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Daily – Vickers Top Buyers & Sellers for 01/24/2022
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.